Clearside Biomedical stockholders elect all three director nominees, approve say-on-pay, ratify E&Y

Clearside Biomedical, Inc.

Directors Croarkin, Humphries, and Hutson elected with ~30M votes for each; no nominee withheld.
Advisory vote on executive compensation approved: 22.8M for, 5.2M against, 6.6M abstentions.
Ratification of Ernst & Young as independent auditor for FY2024 passed: 45.1M for, 4.9M against.
Total shares present at meeting: 50.1M (67% of 74.7M outstanding).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.